Want to see HK:1877 full AI Analyst Report?
Shanghai Junshi Biosciences Co., Ltd. Class H (1877) Revenue
Shanghai Junshi Biosciences Co., Ltd. Class H Revenue
Shanghai Junshi Biosciences Co., Ltd. Class H had a revenue of 817.08M in the quarter ending Sep 30, 2026, with -15.40%. This bring the company's revenue in the last twelve months to 3.18B, Increased 5.98%. In the fiscal year ending Dec 31, 2025, Shanghai Junshi Biosciences Co., Ltd. Class H had annual revenue of 2.43B with 24.92% growth.
- Revenue (ttm)
- 3.18B
- Revenue Growth
- 35.82%
- P/S Ratio
- 12.36
- Revenue/Employee
- HKD 838,360
- Employees
- 2,903
- Market Cap
- HKD 30.07B
Revenue Chart
Shanghai Junshi Biosciences Co., Ltd. Class H Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.43B | 485.44M | 24.92% |
| Dec 31, 2024 | 1.95B | 445.77M | 29.67% |
| Dec 31, 2023 | 1.50B | 49.06M | 3.38% |
| Dec 31, 2022 | 1.45B | -2.57B | -63.89% |
| Mar 31, 2022 | 4.02B | 2.43B | 152.36% |
| Dec 31, 2020 | 1.59B | 819.81M | 105.77% |
| Dec 31, 2019 | 775.09M | 774.15M | 82885.97% |
| Dec 31, 2018 | 934.00K | -214.00K | -18.64% |
| Dec 31, 2017 | 1.15M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.